Tag Archives: treatment

Allopregnanolone Sparks Interest in New PMDD Treatment

Allopregnanolone is all over the place these days.  We have seen several different allopregnanolone derivatives being used to treat postpartum depression (PPD).  Last year, intravenous brexanolone (Zulresso) was approved by the FDA as the first treatment specifically for postpartum depression.  An oral version of allopregnanolone, called zuranolone, is also being pursued as a treatment for… Read More »

Peer-led community intervention substantially reduces treatment failure among adolescents living with HIV in rural Zimbabwe

A peer-led, community-based intervention with multiple components resulted in a 42% reduction in virological failure or death among adolescents living with HIV in rural Zimbabwe compared to adolescents following standard public sector care at 96 weeks follow-up. These findings from an international team led by Dr Webster Mavhu of the Centre for Sexual Health and… Read More »

FDA Approves Fiasp (insulin aspart injection) for the Treatment of Children with Diabetes

Print this page PLAINSBORO, N.J., Jan. 6, 2020 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Fiasp (insulin aspart injection) 100 u/mL for use as a new mealtime insulin option for children with diabetes.1 Fiasp is the first and only fast-acting mealtime insulin injection that does not… Read More »

How much is acne treatment in philippines

Healthy recommendation for DMAE is 50 to 100 milligrams per day. The benefits of EFAS are numerous besides treating blemishes. After the first treatment, you will begin to feel the difference in your skin, as it gradually becomes softer, smoother, tighter and fresher. Reviews are only removed at the reviewer’s request or if they violate… Read More »

FDA Approves Caplyta (lumateperone) for the Treatment of Schizophrenia in Adults

FDA Approves Caplyta (lumateperone) for the Treatment of Schizophrenia in Adults Print this page NEW YORK, Dec. 23, 2019 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that Caplyta (lumateperone) has been approved by the U.S. Food and Drug… Read More »